National Biomedical Research Act
- Last Action
- 6/23/2021
Actions
- 2021-06-23Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2021-06-23Introduced in Senate
CRS Summary
As of 2021-06-23 (00)
National Biomedical Research Act
This bill establishes and makes deposits through FY2030 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration. The fund supports (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative medical research.
Cosponsors (13)
- Edward Markey (D-MA)
- Christopher Murphy (D-CT)
- Tammy Baldwin (D-WI)
- Bernard Sanders (I-VT)
- Timothy Kaine (D-VA)
- Ben Cardin (D-MD)
- Cory Booker (D-NJ)
- Bob Casey (D-PA)
- Richard Blumenthal (D-CT)
- Chris Van Hollen (D-MD)
- Tammy Duckworth (D-IL)
- Alex Padilla (D-CA)
- Ben Luján (D-NM)
Subjects
- Administrative law and regulatory procedures
- Aging
- Appropriations
- Budget deficits and national debt
- Cancer
- Child health
- Computers and information technology
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Education programs funding
- Environmental health
- Executive agency funding and structure
- Food and Drug Administration (FDA)
- Genetics
- Government trust funds
- Health care costs and insurance
- Health information and medical records
- Health personnel
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.